Davis Polk & Wardwell, Zhong Lun Law Firm and have advised Chinese biopharmaceutical company Zai Lab’s on its $761 million secondary listing on the mainboard of the Hong Kong Stock Exchange, with Simpson Thacher & Bartlett and Commerce & Finance Law Offices advising the underwriters.

Zai Lab’s offering follows Yum China Holdings’ recent HKSE cross-listing.  Both companies first listed shares on the NYSE.

Travers Thorp Alberga advised Zai Lab on the offshore aspects of the transaction.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.

Deals

MoFo, Davis Polk lead on Ascendent’s $1.66 bln take-private bid for Hollysys

by Mari Iwata |

Morrison & Foerster and Zhong Lun Law Firm have advised Hong Kong-based private equity firm Ascendent Capital on its $1.66 billion bid to take Chinese automation control system provider Hollysys private. The latter is being represented by Davis Polk & Wardwell and Haiwen & Partners.

Deals

Davis Polk, Zhong Lun guiding Mixue’s billion-dollar HK IPO

by Mari Iwata |

Davis Polk & Wardwell and Zhong Lun Law Firm are advising China's largest bubble-tea chain store, Mixue Bingcheng, on its IPO on the Hong Kong Stock Exchange, which aims to raise between $500 million and $1 billion.